Leveraging its innovative TURBO-ZMTM chemistry technology platform, Zikani Therapeutics harnesses the power of synthetic chemistry and microbiology to develop ribosome modulating agents. These agents are designed to improve the lives of patients suffering from serious infections, particularly those caused by gram-negative bacteria. By focusing on the development and commercialization of therapeutics with limited treatment options, Zikani Therapeutics aims to provide effective solutions for patients in need.